Topotecan in Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group
- 30 June 2000
- journal article
- clinical trial
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 77 (3), 446-449
- https://doi.org/10.1006/gyno.2000.5807
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A phase II study of irinotecan (CPT‐11) in patients with advanced squamous cell carcinoma of the cervixCancer, 1998
- Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacyBritish Journal of Cancer, 1997
- Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.Journal of Clinical Oncology, 1997
- Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1997
- Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitorBritish Journal of Cancer, 1996
- Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion.Journal of Clinical Oncology, 1995
- Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol DesignJNCI Journal of the National Cancer Institute, 1994
- Phase I Clinical and Pharmacology Study of Topotecan Given Daily for 5 Consecutive Days to Patients With Advanced Solid Tumors, With Attempt at Dose Intensification Using Recombinant Granulocyte Colony-Stimulating FactorJNCI Journal of the National Cancer Institute, 1993
- The Current Status of Camptothecin Analogues as Antitumor AgentsJNCI Journal of the National Cancer Institute, 1993
- Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1985